Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in

  News Archive

Plasticell and Pierre Fabre Laboratories Sign a Partnership
Wednesday, February 24, 2016
Company has announced collaboration to identify natural stimulants of brown fat for treatment and prevention of obesity and diabetes.

HIV Modification May Put a Twist on Vaccine and Drug Design
Wednesday, February 24, 2016
Crucial HIV RNA modification called m6A influences viral replication, but wasn’t previously taken into consideration when developing anti-HIV therapies.

Rapid, Highly Sensitive Diagnostics
Tuesday, February 23, 2016
A portable and low-cost diagnostic device has been developed at EPFL. This microfluidic tool, which has been tested with Ebola, requires no bulky equipment. It is thus ideally suited for use in remote regions.

Secret to Promising New Cancer Drug Discovered
Tuesday, February 23, 2016
Researchers have resolved a mystery about how a promising new class of anti-cancer drugs, called nutlins, work - paving the way for improving the future of cancer treatment.

BioAgilytix Acquires IPM Biotech
Tuesday, February 23, 2016
BioAgilytix has announced the acquisition of IPM Biotech, a German-based bioanalytical contract research laboratory renowned for its expertise in large molecule bioanalysis, particularly in the area of immunogenicity.

Myriad Expands Collaboration with TESARO, Merck
Tuesday, February 23, 2016
Companion diagnostic portfolio to evaluate treatment response in patients with triple negative breast cancer or ovarian cancer.

Axol Appoints Paul Andrews to Scientific Advisory Board
Tuesday, February 23, 2016
Phenotypic drug discovery expert joins the stem cell disease model specialists.

Cell Marker for Leukemia-Initiating Capacity
Friday, February 19, 2016
University of Alabama at Birmingham researchers have found a marker on blood cells that may help the most pressing problem in chronic myelogenous leukemia, or CML, today — an inability to get patients off treatment.

Thermo, Children’s Hospital Los Angeles Partner
Friday, February 19, 2016
Children’s Hospital Los Angeles (CHLA) and Thermo Fisher Scientific have agreed to develop a next-generation sequencing (NGS)-based panel designed specifically for pediatric cancer research. The assay would be CHLA’s first NGS panel designed to target biomarkers associated with childhood cancers.

<< 10 11 12 13 14 15 16 >>
Showing Results 121 - 130 of 4197

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos